Proteomic analysis of human serum from patients with chronic kidney disease Y Romanova, A Laikov, M Markelova, R Khadiullina, A Makseev, ... Biomolecules 10 (2), 257, 2020 | 50 | 2020 |
Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option? R Mirgayazova, R Khadiullina, V Chasov, R Mingaleeva, R Miftakhova, ... Genes 11 (6), 704, 2020 | 47 | 2020 |
Key players in the mutant p53 team: Small molecules, gene editing, immunotherapy V Chasov, R Mirgayazova, E Zmievskaya, R Khadiullina, A Valiullina, ... Frontiers in Oncology 10, 1460, 2020 | 38 | 2020 |
Discovery of nanomolar-affinity pharmacological chaperones stabilizing the oncogenic p53 mutant Y220C JR Stephenson Clarke, LR Douglas, PJ Duriez, DI Balourdas, AC Joerger, ... ACS pharmacology & translational science 5 (11), 1169-1180, 2022 | 32 | 2022 |
Promising new tools for targeting p53 mutant cancers: Humoral and cell-based immunotherapies V Chasov, M Zaripov, R Mirgayazova, R Khadiullina, E Zmievskaya, ... Frontiers in Immunology 12, 707734, 2021 | 30 | 2021 |
Novel Isatin-based activator of p53 transcriptional functions in tumor cells R Mirgayazova, R Khadiullina, R Mingaleeva, V Chasov, M Gomzikova, ... Molecular Biology Research Communications 8 (3), 119, 2019 | 25 | 2019 |
Assessment of thermal stability of mutant p53 proteins via differential scanning fluorimetry R Khadiullina, R Mirgayazova, D Davletshin, E Khusainova, V Chasov, ... Life 13 (1), 31, 2022 | 12 | 2022 |
Anticancer therapeutic strategies for targeting mutant p53-Y220C V Chasov, D Davletshin, E Gilyazova, R Mirgayazova, A Kudriaeva, ... Journal of Biomedical Research 38 (3), 222, 2024 | | 2024 |
130P Restoration of the mutant p53 protein upon treatment with small molecule modulators E Gilyazova, D Davletshin, R Khadiullina, R Mirgayazova, V Chasov, ... ESMO Open 8 (1), 2023 | | 2023 |
Reactivation of tumor suppressor p53 by aminobenzothiazole derivatives R Khadiullina, D Davletshin, E Khusainova, R Mirgayazova, V Chasov, ... CELL DEATH DISCOVERY 8, 9-9, 2022 | | 2022 |
Reaktivatsiya mutantnogo onkosupressora R53 proizvodnymi aminobenzotiazola RR Khadiullina, DR Davletshin, EM Khusainova, RM Mirgayazova, ... Genes & Cells 17 (3), 244-244, 2022 | | 2022 |
78P Small molecule compounds targeting the p53 mutants R Khadiullina, R Mirgayazova, D Davletshin, E Khusainova, V Chasov, ... Annals of Oncology 33, S1407, 2022 | | 2022 |
76P Modulation of mutant p53 activity using indazole derivatives D Davletshin, E Khusainova, R Khadiullina, R Mirgayazova, M Baud, ... Annals of Oncology 33, S1406-S1407, 2022 | | 2022 |
77P Targeted compounds for modulation of mutant p53 activity E Khusainova, D Davletshin, R Khadiullina, V Chasov, R Mirgayazova, ... Annals of Oncology 33, S1407, 2022 | | 2022 |
Activation of Mutant Tumor Suppressor p53 Under the Influence of Small Molecule Modulators E Khusainova, D Davletshin, R Khadiullina, R Mirgayazova, V Chasov, ... EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 52, 2022 | | 2022 |
Novel Small molecules with capability to reactivate mutant p53 E Khusainova, R Khadiullina, D Davletshin, R Mirgayazova, V Chasov, ... EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 52, 2022 | | 2022 |
Functional restoration of mutant p53 using targeted small molecule reactivators R Khadiullina, R Mirgayazova, V Chasov, JS Clarke, A Rizvanov, M Baud, ... EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 51, 130-130, 2021 | | 2021 |
Application of CRISPR/Cas9 gene editing to obtain cell lines with various TP53 status R Mirgayazova, R Khadiullina, V Chasov, A Rizvanov, M Baud, E Bulatov EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 51, 130-131, 2021 | | 2021 |
GENERATING TP53 MUTANT MCF7 CELL LINE WITH CRISPR/CAS9: CELL MODEL FOR TARGETED THERAPIES RM Mirgayazova, RR Khadiullina, RN Mingaleeva, M Baud, AA Rizvanov, ... THE INTERNATIONAL CONFERENCE «MOLECULAR MECHANISMS OF AUTOPHAGY IN DISEASES», 30, 2020 | | 2020 |
Restoring impaired functions of mutant tumor suppressor p53 using synthetic modulators RR Khadiullina, RM Mirgayazova, RN Mingaleeva, VV Chasov, M Baud, ... CELL DEATH DISCOVERY 6 (1), 2020 | | 2020 |